Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Psychiatry in Clinical Practice|November 30, 2011
A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorderHisato Matsunaga, Kazuhisa Hayashida, Kensei Maebayashi, et al.
CNS Spectrums|April 24, 2010
Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorderHisato Matsunaga, Kazuhisa Hayashida, Nobuo Kiriike, et al.
Psychiatry Research|May 25, 2010
The clinical utility of symptom dimensions in obsessive-compulsive disorderHisato Matsunaga, Kazuhisa Hayashida, Nobuo Kiriike, et al.
Frontiers in Psychiatry|August 12, 2025
Benefits and barriers associated with using cognitive-behavioral therapy to treat obsessive-compulsive disorder: a narrative reviewKeiichiro Mukai, Yamanishi Kyosuke, Shun Ogino, et al.
The Journal of Clinical Psychiatry|May 9, 2009
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorderHisato Matsunaga, Toshihiko Nagata, Kazuhisa Hayashida, et al.
Comprehensive Psychiatry|February 17, 2005
Impulsive disorders in Japanese adult patients with obsessive-compulsive disorderHisato Matsunaga, Nobuo Kiriike, Tokuzo Matsui, et al.
Psychiatry and Clinical Neurosciences|January 10, 2003
Clinical features in two cases with musical obsessions who successfully responded to clomipramineTokuzo Matsui, Hisato Matsunaga, Kenzo Ohya, et al.
Neuropsychiatric Disease and Treatment|October 22, 2021
Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database AnalysisChika Sakai, Toshinaga Tsuji, Toru Nakai, et al.
BMC Psychiatry|September 30, 2025
The provision of cognitive behavioral therapy in Japan: an analysis using insurance claims dataKeiichiro Mukai, Yukihiko Hosoi, Kyosuke Yamanishi, et al.
Psychiatry and Clinical Neurosciences|August 10, 2004
Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patientsKunitoshi Kamijima, Mitsukuni Murasaki, Masahiro Asai, et al.
Pageof 6